CACNA1C and Familial short QT syndrome: Current guidelines recommend a genetic analysis of only five genes (KCNH2, KCNQ1, KCNJ2, CACNA1C, and CACNB2b) in all clinically diagnosed or suspected SQTS cases due to high lethality (13).